Ömer Erküner

581 total citations
8 papers, 80 citations indexed

About

Ömer Erküner is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Ömer Erküner has authored 8 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 1 paper in Radiology, Nuclear Medicine and Imaging and 0 papers in Infectious Diseases. Recurrent topics in Ömer Erküner's work include Atrial Fibrillation Management and Outcomes (8 papers), Cardiac Arrhythmias and Treatments (7 papers) and Cardiac pacing and defibrillation studies (4 papers). Ömer Erküner is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Cardiac Arrhythmias and Treatments (7 papers) and Cardiac pacing and defibrillation studies (4 papers). Ömer Erküner collaborates with scholars based in Netherlands, Denmark and Australia. Ömer Erküner's co-authors include Harry J.G.M. Crijns, Elton Dudink, Alessandro Capucci, Robby Nieuwlaat, Günter Breithardt, A. John Camm, Michiel Rienstra, Bob Weijs, Cees B. de Vos and Jean‐Yves Le Heuzey and has published in prestigious journals such as The American Journal of Cardiology, International Journal of Cardiology and EP Europace.

In The Last Decade

Ömer Erküner

8 papers receiving 80 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ömer Erküner Netherlands	6	79	8	8	7	6	8	80
Angelina Camiletti Brazil	3	86 1.1×	15 1.9×	4 0.5×	6 0.9×	5 0.8×	5	86
Mariano Badra‐Verdu Canada	7	161 2.0×	6 0.8×	11 1.4×	8 1.1×	8 1.3×	9	162
Evgeny Lyan Germany	9	195 2.5×	15 1.9×	11 1.4×	4 0.6×	3 0.5×	20	202
Tze-Fan Chao Taiwan	3	68 0.9×	3 0.4×	8 1.0×	7 1.0×	3 0.5×	5	72
Y. J. Stevenhagen Netherlands	3	107 1.4×	5 0.6×	5 0.6×	2 0.3×	6 1.0×	7	107
Jan Chovančík Czechia	6	148 1.9×	4 0.5×	5 0.6×	10 1.4×	2 0.3×	28	155
Jorge Rodríguez-Garrido Spain	3	55 0.7×	11 1.4×	9 1.1×	13 1.9×	2 0.3×	7	60
Shelley L. Allen United States	5	206 2.6×	8 1.0×	28 3.5×	4 0.6×	2 0.3×	8	210
Seiji Fukushima Japan	3	27 0.3×	14 1.8×	8 1.0×	13 1.9×	5 0.8×	5	43
Anca Rodica Dan Romania	5	63 0.8×	3 0.4×	5 0.6×	3 0.4×	14 2.3×	13	69

Countries citing papers authored by Ömer Erküner

Since Specialization

Citations

This map shows the geographic impact of Ömer Erküner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Erküner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Erküner more than expected).

Fields of papers citing papers by Ömer Erküner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Erküner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Erküner. The network helps show where Ömer Erküner may publish in the future.

Co-authorship network of co-authors of Ömer Erküner

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Erküner. A scholar is included among the top collaborators of Ömer Erküner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Erküner. Ömer Erküner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Geelhoed, Bastiaan, Ömer Erküner, Hans L. Hillege, et al.. (2023). Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study. EP Europace. 25(4). 1323–1331. 9 indexed citations

Linz, Dominik, Hugo Ten Cate, Henri M.H. Spronk, et al.. (2021). Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies. EP Europace. 24(2). 193–201. 11 indexed citations

Pluymaekers, Nikki A H A, Elton Dudink, Bob Weijs, et al.. (2021). Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation. Netherlands Heart Journal. 29(5). 255–261. 7 indexed citations

Erküner, Ömer, Elton Dudink, Robby Nieuwlaat, et al.. (2018). Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey). The American Journal of Cardiology. 122(4). 578–583. 12 indexed citations

Pluymaekers, Nikki A H A, Elton Dudink, Lucas V.A. Boersma, et al.. (2018). External electrical cardioversion in patients with cardiac implantable electronic devices: Is it safe and is immediate device interrogation necessary?. Pacing and Clinical Electrophysiology. 41(10). 1336–1340. 6 indexed citations

Erküner, Ömer, et al.. (2017). Stroke risk in patients with device-detected atrial high-rate episodes. Netherlands Heart Journal. 26(4). 177–181. 4 indexed citations

Dudink, Elton, Ömer Erküner, Jenny Berg, et al.. (2017). The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. EP Europace. 20(6). 929–934. 30 indexed citations

Erküner, Ömer, Ron Pisters, Elton Dudink, et al.. (2016). Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events. International Journal of Cardiology. 225. 337–341. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact